NeuroMetrix Introduces Quell 2.0 Wearable AI Pain Relief Technology at CES 2019
NeuroMetrix, an innovation-driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes, launched a revolutionary wearable device called Quell 2.0 that uses artificial intelligence to relieve pain at CES 2019.
Transcutaneous electrical nerve stimulation (TENS) therapy is for the treatment of chronic pain. The therapy has been around for decades, but NeuroMetrix is taking TENS therapy to a new level with its new device.
We're here for you.or call 800.204.6577